Novatek International is pleased to announce SAJA Pharmaceuticals, has chosen Novatek’s Quality Management System, Nova-QMS from the Novatek LIMS suite of products for their Jeddah manufacturing site located in Saudi Arabia. Nova-QMS is a process-driven application comprised of integrated components such as document management, audit management, training management, CAPA, change control, incidents and deviations management, complaint management, equipment calibration and investigation. Nova-QMS enables organizations to increase efficiencies and achieve compliance by integrating related events and actions, streamlining workflow, and facilitating trending and reporting across all quality systems. Novatek is pleased to welcome SAJA to our global Nova-LIMS clients portfolio!
About SAJA Pharmaceuticals Co. Ltd.
SAJA is a joint venture between the premier Saudi healthcare company, Tamer, the Saudi partner, the (SA) in SAJA and two of the leading Japanese pharmaceutical companies, Daiichi Sankyo Co., Ltd. and Astellas Pharma Inc., the Japanese partners, the (JA) in SAJA. Both companies are major players in the Japanese healthcare sector, each with an impressive portfolio of ethical medicines. SAJA Pharmaceuticals covers a wide range of Therapeutic classes; urology, Cardiovascular, GIT, Osteoporosis, NSAIDs, and Anti-infective drugs. SAJA Pharmaceuticals distributes their products extensively throughout the UAE , Egypt and greater Africa. To learn more about SAJA Pharmaceuticals, visit them online at: http://www.sajaonline.net
